Teeft.i
Checkpoint
Istex
Racine
Checkpoint
Istex
Exploration
Accueil
Racine
Racine

Serveur d'exploration H2N2 - Checkpoint (Istex)

Index « Teeft.i » - entrée « Recombinant »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Recombinaisnns < Recombinant < Recombinant acnpv  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 154.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000108 (2012) Glendie Marcelin [États-Unis] ; Matthew R. Sandbulte [États-Unis] ; Richard J. Webby [États-Unis]Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines
000459 (2006) S. Smith [Royaume-Uni] ; V. Demicheli ; C. Di Pietrantonj ; Ar Harnden ; T. Jefferson ; Nj Matheson ; A. RivettiVaccines for preventing influenza in healthy children
000536 (2005) Derrick Louz [Pays-Bas] ; Hans E. Bergmans [Pays-Bas] ; Birgit P. Loos [Pays-Bas] ; Rob C. Hoeben [Pays-Bas]Cross‐species transfer of viruses: implications for the use of viral vectors in biomedical research, gene therapy and as live‐virus vaccines
000621 (2002) Gabriele Neumann [États-Unis] ; Yoshihiro Kawaoka [États-Unis, Japon]Generation of influenza A virus from cloned cDNAs — historical perspective and outlook for the new millenium
000668 (2001) Erich Hoffmann [États-Unis] ; Nannan Zhou [États-Unis] ; Robert G. Webster [États-Unis]Eight-plasmid rescue system for influenza A virus
000671 (2001) J. M. Wood [Royaume-Uni] ; K. G. Nicholson [Royaume-Uni] ; M. Zambon [Royaume-Uni] ; R. Hinton [Royaume-Uni] ; D. L. Major [Royaume-Uni] ; R. W. Newman [Royaume-Uni] ; U. Dunleavy [Royaume-Uni] ; D. Melzack [Royaume-Uni] ; J. S. Robertson [Royaume-Uni] ; G. C. Schild [Royaume-Uni]Developing vaccines against potential pandemic influenza viruses
000690 (2001) Gabriele Neumann [États-Unis] ; Yoshihiro Kawaoka [États-Unis]Reverse Genetics of Influenza Virus
000691 (2001) R. Arnon ; R. Tarrab-Hazdai ; T. Ben-YedidiaPeptide-based Synthetic Recombinant Vaccines with Anti-viral Efficacy
000695 (2001) M. D Wareing [Australie] ; G. A Tannock [Australie]Live attenuated vaccines against influenza; an historical review
000700 (2001) Diane L. Larsen [États-Unis] ; Alexander Karasin [États-Unis] ; Christopher W. Olsen [États-Unis]Immunization of pigs against influenza virus infection by DNA vaccine priming followed by killed-virus vaccine boosting
000711 (2001) Alexander C. Schmidt [États-Unis] ; Robert B. Couch [États-Unis] ; George J. Galasso [États-Unis] ; Frederick G. Hayden [États-Unis] ; John Mills [Australie] ; Brian R. Murphy [États-Unis] ; Robert M. Chanock [États-Unis]Current research on respiratory viral infections: Third International Symposium
000724 (2000) V. Demicheli [Italie] ; T. Jefferson [Royaume-Uni] ; D. Rivetti [Italie] ; J. Deeks [Royaume-Uni]Prevention and early treatment of influenza in healthy adults
000790 (1999) A. Michael Frace [États-Unis] ; Alexander I. Klimov [États-Unis] ; Thomas Rowe [États-Unis] ; Renee A. Black [États-Unis] ; Jacqueline M. Katz [États-Unis]Modified M2 proteins produce heterotypic immunity against influenza A virus
000808 (1999) Hiroshi Kido [Japon] ; Yoshihito Beppu [Japon] ; Yasuhiro Imamura [Japon] ; Ye Chen [Japon] ; Meiko Murakami [Japon] ; Kumiko Oba [Japon] ; Takae Towatari [Japon]The human mucus protease inhibitor and its mutants are novel defensive compounds against infection with influenza A and Sendai viruses
000809 (1999) Hunein F. Maassab [États-Unis] ; Martin L. Bryant [États-Unis]The development of live attenuated cold‐adapted influenza virus vaccine for humans
000816 (1999) David A. Steinhauer [Royaume-Uni]Role of Hemagglutinin Cleavage for the Pathogenicity of Influenza Virus
000857 (1998) James E. Crowe Jr. [États-Unis]Immune responses of infants to infection with respiratory viruses and live attenuated respiratory virus candidate vaccines
000901 (1998) Michael W. Shaw [États-Unis] ; Irina V. Kiseleva [Russie] ; Andrei Y. Egorov [Russie] ; Mark L. Hemphill [États-Unis] ; Xiyan Xu [États-Unis]Generation of influenza transfectants using purified recombinant nucleocapsid protein
000913 (1998) Stephen S. Whitehead ; Cai-Yen Firestone ; Peter L. Collins ; Brian R. MurphyA Single Nucleotide Substitution in the Transcription Start Signal of the M2 Gene of Respiratory Syncytial Virus Vaccine Candidate cpts 248/404 Is the Major Determinant of the Temperature-Sensitive and Attenuation Phenotypes
000942 (1997) C. Svanholm [Suède] ; H. Wigzell [Suède]Amplification of T-cell responses in DNA-based immunization with HIV-1 Nef by coinjection with a GM-CSF expression vector
000966 (1997) Edwin D. Kilbourne [États-Unis]In pursuit of influenza: Fort monmouth to valhalla (and back)

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Istex/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Teeft.i -k "Recombinant" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Teeft.i  \
                -Sk "Recombinant" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Istex
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Recombinant
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021